Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Promyelocytic, Acute × Leukocyte Count × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Promyelocytic, Acute 1 Graft vs Host Disease 1

Interventions

Arsenic Trioxide 23 Tretinoin 21 Cytarabine 18 Idarubicin 12 Cyclophosphamide 12 Filgrastim 10 Methotrexate 9 Busulfan 9 Etoposide 8 fludarabine phosphate 6 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Gemtuzumab 6 Daunorubicin 6 Mitoxantrone 5 Mercaptopurine 5 Clofarabine 5 Vorinostat 4 Topotecan 4 Tacrolimus 4 Antilymphocyte Serum 4 Sorafenib 3 Mycophenolic Acid 3 Granulocyte Colony-Stimulating Factor 3 Bortezomib 3 venetoclax 2 tamibarotene 2 sargramostim 2 romidepsin 2 lintuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04562818 2020-09-24

Mexico APL

Instituto Nacional de Cancerologia de Mexico

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡